Other
Tonsillitis
19
Pipeline Programs↗
1
Active Trials↗
10
Companies Involved↗
Tonsillitis is an emerging landscape with 19 programs across 10 companies. The most active players are Sanofi, Jiangxi Qingfeng Pharmaceutical Co. Ltd., Fresenius Kabi Oncology Ltd.. 12 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical4
Phase 1
No programs
Phase 2
No programs
Analysis
Trial Status
10
clinical trials
Completed4 · 40%
Terminated3 · 30%
Unknown status2 · 20%
Active, not recruiting1 · 10%
Clinical Trials
Trial Activity
10 trials
Bacteriophage Therapy in Tonsillitis
Active, not recruiting·TTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan·Phase 3·NCT04682964·128 enrolled
Bacteriological Study of Acute Follicular Tonsillitis
Unknown status·—·N/A·NCT04321733·66 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)